Phathom Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $7,324 | $1,912 | $682 | $0 |
Gross Profit | 5,948 | 1,486 | 905 | -121 |
EBITDA | -77,103 | -69,740 | -66,356 | -35,659 |
EBIT | -77,300 | -69,954 | -66,541 | -35,780 |
Net Income | -91,446 | -82,852 | -79,570 | -43,243 |
Net Change In Cash | 7,324 | 1,912 | 682 | 0 |
Free Cash Flow | -70,767 | -69,060 | -44,272 | -32,853 |
Cash | 276,237 | 322,229 | 381,393 | 213,677 |
Basic Shares | 58,558 | 58,371 | 51,289 | 56,782 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $682 | $0 | $0 | $0 |
Gross Profit | 515 | -620 | -521 | -300 |
EBITDA | -159,049 | -170,418 | -137,095 | -124,582 |
EBIT | -159,624 | -171,038 | -137,616 | -124,882 |
Net Income | -201,592 | -223,006 | -148,094 | -133,318 |
Net Change In Cash | 682 | 0 | 0 | 0 |
Cost of Revenue | -104,237 | 43,731 | ||
Free Cash Flow | -139,214 | -147,571 | -148,945 | -70,728 |
Cash | 381,393 | 155,385 | 183,259 | 287,496 |
Basic Shares | 51,289 | 39,118 | 37,002 | 33,228 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.56 |
2024-03-31 | -$1.42 |
2023-12-31 | -$1.39 |
2023-09-30 | -$0.76 |
